The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative
ConclusionElevated preoperative CA19-9 portends worse PFS, while elevated CEA predicts worse OS after CRS/HIPEC in patients with MACA. This study provides additional evidence that CA19-9 and CEA levels should be collected during standard preoperative bloodwork, while CA-125 can likely be omitted. Tumor differentiation, when added to preoperative tumor marker levels, provides powerful prognostic information. Prospective studies are required to confirm this association.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Adenocarcinoma | Appendicitis | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | Gastroenterology | Maca | Mucinous Carcinoma | Peritoneal Cancer | Study | Surgery | USA Health